CureVac NV【CVAC】銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

3.10

買値

3.00

売値

3.14

出来高

820,936

2.83 日の範囲 3.02

2.215 52 週間の範囲 5.28

時価総額

694.365M

前日終値

2.99

始値

2.86

時刻

3.08

最終取引時間

財務取引量

US$ 2,379,495

VWAP

2.8985

平均取引量 (3 か月)

495,838

発行済株式数

223,988,675

配当利回り

PER

-2.48

1 株当たり利益 (EPS)

-1.16

歳入

61.71M

純利益

-260.17M

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-gen... CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-generation COVID-19 vaccine. CureVac's first attempt to develop a COVID-19 vaccine did not have sufficient efficacy data, and its trials were discontinued in October 2021. The company's other pipeline candidates include mRNA vaccines for influenza, rabies, and malaria. Additionally, CureVac is in the early stages of development for oncology and molecular therapies spanning tumors, liver, ocular, and lung diseases. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.curevac.com

本社

Tubingen, Deu

設立

CureVac NV is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker CVAC. The last closing price for CureVac NV was US$2.99. Over the last year, CureVac NV shares have traded in a share price range of US$ 2.215 to US$ 5.28.

CureVac NV currently has 223,988,675 shares in issue. The market capitalisation of CureVac NV is US$669.73 million. CureVac NV has a price to earnings ratio (PE ratio) of -2.48.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.11	-3.42679127726	3.21	3.23	2.68	590773	2.95929158	CS
4	0.5493	21.5352648293	2.5507	3.51	2.528	552483	2.99707435	CS
12	0.02	0.649350649351	3.08	3.51	2.37	495838	2.8611301	CS
26	-0.28	-8.28402366864	3.38	3.87	2.37	635302	3.148076	CS
52	-1.16	-27.2300469484	4.26	5.28	2.215	845615	3.44191778	CS
156	-37.52	-92.368291482	40.62	41.09	2.215	720066	8.2998276	CS
260	-81.89	-96.3525120602	84.99	151.8	2.215	791901	33.61579634	CS

CVAC - Frequently Asked Questions (FAQ)

What is the current CureVac NV share price?

The current share price of CureVac NV is US$ 3.10

How many CureVac NV shares are in issue?

CureVac NV has 223,988,675 shares in issue

What is the market cap of CureVac NV?

The market capitalisation of CureVac NV is USD 669.73M

What is the 1 year trading range for CureVac NV share price?

CureVac NV has traded in the range of US$ 2.215 to US$ 5.28 during the past year

What is the PE ratio of CureVac NV?

The price to earnings ratio of CureVac NV is -2.48

What is the cash to sales ratio of CureVac NV?

The cash to sales ratio of CureVac NV is 10.45

What is the reporting currency for CureVac NV?

CureVac NV reports financial results in EUR

What is the latest annual turnover for CureVac NV?

The latest annual turnover of CureVac NV is EUR 61.71M

What is the latest annual profit for CureVac NV?

The latest annual profit of CureVac NV is EUR -260.17M

What is the registered address of CureVac NV?

The registered address for CureVac NV is FRIEDRICH-MIESCHER-STRASSE 15, TUBINGEN, 72076

What is the CureVac NV website address?

The website address for CureVac NV is www.curevac.com

Which industry sector does CureVac NV operate in?

CureVac NV operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
MYSZMy Size Inc	US$ 4.2001 (211.12%)	121.03M
NVNINVNI Group Ltd	US$ 8.26 (209.36%)	78.06M
TPICTPI Composites Inc	US$ 2.45 (100.82%)	34M
ICGIntchains Group Ltd	US$ 8.77 (88.60%)	527.94k
HSDTHelius Medical Technologies Inc	US$ 0.884851 (84.34%)	121.95M
CYNCYNGN Inc	US$ 0.4603 (-71.41%)	27.91M
MTEMMolecular Templates Inc	US$ 0.1502 (-57.09%)	8.75M
PRFXPainReform Ltd	US$ 5.15 (-53.85%)	2.94M
GALTGalectin Therapeutics Inc	US$ 1.03 (-48.50%)	9.27M
BCABBioAtla Inc	US$ 0.6923 (-41.82%)	6.25M
EDBLEdible Garden AG Inc	US$ 0.24 (65.06%)	354.32M
APTOAptose Biosciences Inc	US$ 0.28 (64.51%)	305.1M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.606999 (6.49%)	292.16M
NVDANVIDIA Corporation	US$ 134.70 (3.08%)	287.21M
PLTRPalantir Technologies Inc	US$ 80.55 (8.54%)	277.63M